Soleno Therapeutics, Inc. Profile Avatar - Palmy Investing

Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily ora…

Biotechnology
US, Redwood City [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SLNO's Analysis
CIK: 1484565 CUSIP: 834203200 ISIN: US8342033094 LEI: - UEI: -
Secondary Listings
SLNO has no secondary listings inside our databases.